ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers-Reference-Cited by-同舟云学术

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers

Published:2021-04 Issue:4 Volume:29 Page:1585-1601
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Day Evan K.,Campbell Anne,Pandolf Ashley,Rogerson Troy,Zhong Qing,Xiao Aizhen,Purow Benjamin,Lazzara Matthew J.

Funder

American Cancer Society

National Science Foundation of Sri Lanka

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference57 articles.

1. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives;Greco;J. Cell. Physiol.,2001

2. A phase I/II study of herpes simplex virus type 1 thymidine kinase “suicide” gene therapy for recurrent glioblastoma;Klatzmann;Hum. Gene Ther.,1998

3. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme;Rainov;Hum. Gene Ther.,2000

4. Progress and problems with the use of viral vectors for gene therapy;Thomas;Nat. Rev. Genet.,2003

5. Tissue-specific promoters for cancer gene therapy;Saukkonen;Expert Opin. Biol. Ther.,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Histone Methylation–MAPK Signaling Axis Drives Durable Epithelial–Mesenchymal Transition in Hypoxic Pancreatic Cancer;Cancer Research;2024-03-12

2. Suicide Gene Delivery System Mediated by Ultrasound-Targeted Microbubble Destruction: A Promising Strategy for Cancer Therapy;Human Gene Therapy;2022-12-01

3. A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreas cancer;2022-10-20

4. Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling;Stem Cell Research & Therapy;2022-05-12

5. The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting;Cancers;2022-03-14